Bond Lilly & Company 2.35% ( US532457BQ09 ) in USD
| Issuer | Lilly & Company |
| Market price | 100 % ▼ |
| Country | United States
|
| ISIN code |
US532457BQ09 ( in USD )
|
| Interest rate | 2.35% per year ( payment 2 times a year) |
| Maturity | 15/05/2022 - Bond has expired |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 2 000 USD |
| Total amount | 750 000 000 USD |
| Cusip | 532457BQ0 |
| Standard & Poor's ( S&P ) rating | A+ ( Upper medium grade - Investment-grade ) |
| Moody's rating | A2 ( Upper medium grade - Investment-grade ) |
| Detailed description |
Eli Lilly and Company is a global pharmaceutical company that researches, develops, manufactures, and markets pharmaceutical products, including medications for diabetes, oncology, immunology, and neuroscience. The Bond issued by Lilly & Company ( United States ) , in USD, with the ISIN code US532457BQ09, pays a coupon of 2.35% per year. The coupons are paid 2 times per year and the Bond maturity is 15/05/2022 The Bond issued by Lilly & Company ( United States ) , in USD, with the ISIN code US532457BQ09, was rated A2 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Lilly & Company ( United States ) , in USD, with the ISIN code US532457BQ09, was rated A+ ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
Français
Italiano
United States